BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 22, 2009
View Archived Issues
GLURP-MSP3 hybrid malaria vaccine found safe and immunogenic in phase I trial
Read More
Phase I data links antiangiogenic effects of Ang-(1-7) to reduced PIGF levels in solid tumors
Read More
Phase II data show thromboprophylactic effects of TAK-442 after total knee replacement
Read More
Preliminary phase I data disclosed on MDX-1342 in relapsed/refractory CLL
Read More
ABT-869/paclitaxel shows preliminary antitumor activity in patients with breast cancer
Read More
Eisai to acquire AkaRx and thrombocytopenia therapeutic AKR-501
Read More
Labopharm initiates European regulatory approval process for tramadol/acetaminophen
Read More
ThromboGenics completes enrollment in second phase III trial of microplasmin
Read More
Synta initiates phase II trial of STA-9090 in non-small cell lung cancer
Read More
Keryx begins phase III registration trial of perifosine in multiple myeloma
Read More
Naurex initiates phase I trial of NMDA modulator GLYX-13 for depression
Read More
Anadys reports 4-week results of phase II trial of ANA-598 in hepatitis C
Read More
Durect reports encouraging data from phase IIb trial of Posidur in postsurgical pain
Read More
Ariad completes enrollment in phase III trial of ridaforolimus in metastatic sarcoma
Read More
Arno Therapeutics enrolls first patient in phase II trial of AR-67 in glioblastoma multiforme
Read More
Ligand and Neurogen amend merger agreement
Read More
Clinuvel reports preliminary phase III results of afamelanotide in polymorphic light eruption
Read More
Almirall and Forest Laboratories expand respiratory collaboration with LAS-100977
Read More
FDA's advisory committee votes on benefit-risk of Crestor in JUPITER study
Read More
Hiroshima University identifies novel compounds with oncolytic and antibacterial activity
Read More
Novel MST1R and HGFR kinase inhibitors identified by OSI as oncolytics
Read More
CB1 antagonists for the treatment of obesity described by sanofi-aventis
Read More
CSIRO claims novel antimicrobial agents for bacterial and fungal infections
Read More
NOS-2 inhibitors disclosed by Brazilian scientists for the treatment of inflammatory disorders
Read More
Abbott describes histamine receptor ligands for the treatment of asthma
Read More